Correction of anemia with epoetin alfa in chronic kidney disease
Open accessAbstract
BACKGROUND: Anemia, a common complication of chronic kidney disease, usually develops as a consequence of erythropoietin deficiency. Recombinant human erythropoietin (epoetin alfa) is indicated for the correction of anemia associated with this condition. However, the optimal level of hemoglobin correction is not defined. METHODS: In this open-label trial, we studied 1432 patients with chronic kidney disease, 715 of whom were randomly assigned to receive a dose of epoetin alfa targeted to achieve a hemoglobin level of 13.5 g per deciliter and 717 of whom were assigned to receive a dose targeted to achieve a level of 11.3 g per deciliter. The median study duration was 16 months. The primary end point was a composite of death, myocardial infarction, hospitalization for congestive heart failure (without renal replacement therapy), and stroke. RESULTS: A total of 222 composite events occurred: 125 events in the high-hemoglobin group, as compared with 97 events in the low-hemoglobin group (hazard ratio, 1.34; 95% confidence interval, 1.03 to 1.74; P=0.03). There were 65 deaths (29.3%), 101 hospitalizations for congestive heart failure (45.5%), 25 myocardial infarctions (11.3%), and 23 strokes (10.4%). Seven patients (3.2%) were hospitalized for congestive heart failure and myocardial infarction combined, and one patient (0.5%) died after having a stroke. Improvements in the quality of life were similar in the two groups. More patients in the high-hemoglobin group had at least one serious adverse event. CONCLUSIONS: The use of a target hemoglobin level of 13.5 g per deciliter (as compared with 11.3 g per deciliter) was associated with increased risk and no incremental improvement in the quality of life. (ClinicalTrials.gov number, NCT00211120 [ClinicalTrials.gov].).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079 · see citing works
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681 · see citing works
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614 · see citing works
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310 · see citing works
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310 · see citing works
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,094 · see citing works
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930 · see citing works
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J. L., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,876 · see citing works
Jones, M., Ibels, L. S., Schenkel, B., & Zagari, M. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 1,812 · see citing works
Group Sequential Methods with Applications to Clinical Trials
Jennison, C., & Turnbull, B. W. (1999) · Chapman & Hall/CRC eBooks · doi:10.1201/9780367805326 · Cited by 1,361 · see citing works
Development of the Kidney Disease Quality of Life (KDQOLTM) Instrument
Hays, R. D., Kallich, J., Mapes, D., Coons, S. J., & Carter, W. B. (1994) · Quality of Life Research · doi:10.1007/bf00451725 · Cited by 1,126 · see citing works
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.010 · Cited by 829 · see citing works
Interim analysis: The alpha spending function approach
DeMets, D. L., & Lan, K. K. G. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131308 · Cited by 565 · see citing works
Gouva, C., Nikolopoulos, P. M., Ioannidis, J. P. A., & Siamopoulos, K. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00797.x · Cited by 407 · see citing works
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Foley, R. N., Parfrey, P. S., Morgan, J. M., Barré, P. E., Campbell, P., Cartier, P., Coyle, D., Fine, A., Handa, P., Kingma, I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00289.x · Cited by 405 · see citing works
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70008-x · Cited by 401 · see citing works
Parfrey, P., Foley, R., Wittreich, B. H., Sullivan, D. J., Zagari, M., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 399 · see citing works
Collins, A. J., Li, S., Peter, W. L. S., Ebben, J., Roberts, T. L., Ma, J. Z., & Manning, W. G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112465 · Cited by 301 · see citing works
Furuland, H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.353 · Cited by 223 · see citing works
Roger, S. D., McMahon, L. P., Clarkson, A. R., Disney, A. P. S., Harris, D. C. H., Hawley, C. M., Healy, H. G., Kerr, P. G., Lynn, K. L., Parnham, A., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102471.89084.8b · Cited by 212 · see citing works
Levin, A., Djurdjev, O., Thompson, C., Barrett, B. J., Ethier, J. H., Carlisle, E., Barré, P. E., Magner, P. O. C., Muirhead, N., Tobe, S. W., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.007 · Cited by 191 · see citing works
Coates, A. S., Dillenbeck, C. F., McNeil, D., Kaye, S. B., Sims, K., Fox, R. M., Woods, R. L., Milton, G. W., Solomon, J., & Tattersall, M. H. N. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90096-2 · Cited by 156 · see citing works
Hemoglobin Targets for the Anemia of Chronic Kidney Disease
Strippoli, G. F., Craig, J. C., Manno, C., & Schena, F. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145436.09176.a7 · Cited by 151 · see citing works
Levin, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.7.x · Cited by 131 · see citing works
Effect of Early Correction of Anemia on the Progression of CKD
Rossert, J., Levin, A., Roger, S. D., Hörl, W. H., Fouqueray, B. L., Gassmann-Mayer, C., Frei, D. W., & McClellan, W. M. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.170 · Cited by 130 · see citing works
Ross, S. D., Fahrbach, K. R., Frame, D., Scheye, R., Connelly, J. E., & Glaspy, J. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80170-4 · Cited by 114 · see citing works
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Strippoli, G. F., Navaneethan, S. D., Craig, J. C., & Palmer, S. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003967.pub2 · Cited by 106 · see citing works
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
Xue, J. L., Peter, W. L. S., Ebben, J. P., Everson, S. E., & Collins, A. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36861 · Cited by 101 · see citing works
Estimation and sample size considerations for clustered binary responses
Lee, E. W., & Dubin, N. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131206 · Cited by 88 · see citing works
McMahon, L. P., Roger, S. D., & Levin, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130566.69170.5e · Cited by 82 · see citing works
Association of Kidney Function With Anemia
Astor, B. C., Muntner, P., Levin, A., Eustace, J. A., & Coresh, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1401 · Cited by 74 · see citing works
Target Hemoglobin Level for EPO Therapy in CKD
Parfrey, P. S. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.11.001 · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800 · see citing works
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,102 · see citing works
Authors Task Force Members, Hamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,069 · see citing works
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213 · see citing works
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,129 · see citing works
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096 · see citing works
Self-citationNormalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,094 · see citing works
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841 · see citing works
Jones, M., Ibels, L. S., Schenkel, B., & Zagari, M. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 1,812 · see citing works
Kalantar‐Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,149 · see citing works
Hamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., et al. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.006 · Cited by 1,061 · see citing works
Babitt, J. L., & Lin, H. Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111078 · Cited by 1,041 · see citing works
Herzog, C. A., ASINGER, R. W., Berger, A. K., Charytan, D. M., Dı́ez, J., Hart, R. G., Eckardt, K., Kasiske, B. L., McCullough, P. A., PASSMAN, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 918 · see citing works
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A. P., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G. G., Miguel, J. F. S., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840 · see citing works
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787 · see citing works
Anemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764 · see citing works
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.008 · Cited by 726 · see citing works
Phrommintikul, A., Haas, S. J., Elsik, M., & Krum, H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60194-9 · Cited by 633 · see citing works
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.564872 · Cited by 605 · see citing works
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M. J., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 598 · see citing works
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Swedberg, K. B., Young, J. B., Anand, I. S., Cheng, S., Desai, A. S., Díaz, R., Maggioni, A. P., McMurray, J. J. V., O’Connor, C. J., Pfeffer, M. A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214865 · Cited by 589 · see citing works
Anemia and Iron Deficiency in Heart Failure
Anand, I. S., & Gupta, P. (2018) · Circulation · doi:10.1161/circulationaha.118.030099 · Cited by 600 · see citing works
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
Chen, N., Hao, C., Peng, X., Lin, H., Yin, A., Hao, L., Tao, Y., Liang, X., Liu, Z., Xing, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813599 · Cited by 582 · see citing works
Self-citationChronic Kidney Disease and Its Complications
Thomas, R., Kanso, A. A., & Sedor, J. R. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.01.008 · Cited by 567 · see citing works
Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient
Stenvinkel, P., Carrero, J. J., Axelsson, J., Lindholm, B., Heimbürger, O., & Massy, Z. A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 567 · see citing works
Efficacy and Safety of Epoetin Alfa in Critically Ill Patients
Corwin, H. L., Gettinger, A., Fabian, T. C., May, A. K., Pearl, R. G., Heard, S. O., An, R., Bowers, P., Burton, P. B. J., Klausner, M. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071533 · Cited by 546 · see citing works
Biomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 546 · see citing works
Goodnough, L. T., Maniatis, A. G., Earnshaw, P. H., Benoni, G., Beris, P., Bisbe, E., Fergusson, D. A., Gombotz, H., Habler, O. P., Monk, T. G., et al. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq361 · Cited by 541 · see citing works
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Szczech, L. A. M., Barnhart, H. X., Inrig, J. K., Reddan, D. N., Sapp, S. K., Califf, R. M., Patel, U. D., & Singh, A. K. (2008) · Kidney International · doi:10.1038/ki.2008.295 · Cited by 527 · see citing works
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502 · see citing works
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J. V., Murray, H. M., Tomson, C., Wheeler, D. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1810742 · Cited by 509 · see citing works
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
Solomon, S. D., Uno, H., Lewis, E. F., Eckardt, K.-U., Lin, J., Burdmann, E. A., de Zeeuw, D., Ivanovich, P., Levey, A. S., Parfrey, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005109 · Cited by 473 · see citing works
Locatelli, F., Barany, P. F., Covic, A. C., de Francisco, A., Vecchio, L. D., Goldsmith, D. J. A., Hörl, W. H., London, G. M., Vanholder, R. C., Biesen, W. V., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft033 · Cited by 478 · see citing works
End-Stage Renal Disease in the United States
Foley, R. N., & Collins, A. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020220 · Cited by 459 · see citing works
Bock, J. S., & Gottlieb, S. S. (2010) · Circulation · doi:10.1161/circulationaha.109.886473 · Cited by 453 · see citing works
Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention
Drew, D. A., Weiner, D. E., & Sarnak, M. J. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.017 · Cited by 459 · see citing works
Gupta, N., & Wish, J. B. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.011 · Cited by 447 · see citing works
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., OJO, A. O., Zhang, X., Nessel, L. C., Hamano, T., Grunwald, J. E., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050465 · Cited by 443 · see citing works
Guidelines for the management of chronic kidney disease
Levin, A., Hemmelgarn, B. R., Culleton, B. F., Tobe, S. W., McFarlane, P., Ruzicka, M., Burns, K. D., Manns, B., White, C., Madore, F., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080351 · Cited by 417 · see citing works
How the Target Hemoglobin of Renal Anemia Should Be?
Mimura, I., Tanaka, T., & Nangaku, M. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000440849 · Cited by 416 · see citing works
Toblli, J. E., Lombraña, A., Duarte, P. J., & Gennaro, F. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.029 · Cited by 415 · see citing works
KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease
Woo, K. T., & Chan, C. M. (2011) · Kidney International · doi:10.1038/ki.2011.202 · Cited by 412 · see citing works
Effects of graded doses of testosterone on erythropoiesis in healthy young and older men
Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1692 · Cited by 404 · see citing works
Coyne, D. W., Kapoian, T., Suki, W. N., Singh, A. K., Moran, J., Dahl, N. V., & Rizkala, A. R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091034 · Cited by 391 · see citing works
Himmelfarb, J., & Ikizler, T. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0902710 · Cited by 397 · see citing works
Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Portolés, J. M., Martín-Rodriguez, L., Broseta, J. J., & Cases, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.642296 · Cited by 417 · see citing works
Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P. A., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad083 · Cited by 385 · see citing works
Erythropoietin after a century of research: younger than ever
JELKMANN, W. E. B. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 365 · see citing works
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Tonelli, M. A., Garg, A. X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00252 · Cited by 361 · see citing works
Jhamb, M., Weisbord, S. D., Steel, J. L., & Unruh, M. L. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.005 · Cited by 359 · see citing works
The non‐haematopoietic biological effects of erythropoietin
Arcasoy, M. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07014.x · Cited by 347 · see citing works
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
Batchelor, E. K., Kapitsinou, P. P., Pérgola, P. E., Kovesdy, C. P., & Jalal, D. I. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020213 · Cited by 349 · see citing works
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 331 · see citing works
Macdougall, I. C., Böck, A., Carrera, F., Eckardt, K., Gaillard, S., Wyck, D. V., Roubert, B., Nolen, J., Roger, S. D., & on behalf of the FIND-CKD Study Investigators (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu201 · Cited by 331 · see citing works
Chronic Kidney Disease in Small Animals
Polzin, D. J. (2010) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2010.09.004 · Cited by 317 · see citing works
Anemia and Chronic Heart Failure
Anand, I. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.044 · Cited by 314 · see citing works
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Koury, M. J., & Haase, V. H. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.82 · Cited by 313 · see citing works
Atherosclerosis in Chronic Kidney Disease
Valdivielso, J. M., Rodrı́guez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., & Ortíz, A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312705 · Cited by 311 · see citing works
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
Mimura, I., & Nangaku, M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.124 · Cited by 300 · see citing works
The heart and vascular system in dialysis
Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 302 · see citing works
Chronic kidney disease in the elderly: evaluation and management
Mallappallil, M. C., Friedman, E. A., Delano, B. G., McFarlane, S. I., & Salifu, M. O. (2014) · Clinical Practice · doi:10.2217/cpr.14.46 · Cited by 305 · see citing works
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Mikhail, A. I., Brown, C., Williams, J. A., Mathrani, V., Shrivastava, R., Evans, J., Isaac, H., & Bhandari, S. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0688-1 · Cited by 305 · see citing works
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T., & Kaelin, W. G. (2008) · Blood · doi:10.1182/blood-2007-10-117812 · Cited by 294 · see citing works
Provenzano, R., Besarab, A., Sun, C. H., Diamond, S. A., Durham, J. H., Cangiano, J. L., Aiello, J. R., Novak, J. E., Lee, T. T., Leong, R., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06890615 · Cited by 295 · see citing works
Pharmacologic Targeting of Hypoxia-Inducible Factors
Semenza, G. L. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021637 · Cited by 288 · see citing works
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
Maxwell, P. H., & Eckardt, K. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.193 · Cited by 286 · see citing works
Besarab, A., Provenzano, R., Hertel, J., Zabaneh, R. I., Klaus, S. J., Lee, T. T., Leong, R., Hemmerich, S., Yu, K.-H. P., & Neff, T. B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv302 · Cited by 289 · see citing works
Erythropoietin deficiency decreases vascular stability in mice
Chen, J., Connor, K. M., Aderman, C. M., & Smith, L. E. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33813 · Cited by 280 · see citing works
Evaluation and management of anemia in the elderly
Goodnough, L. T., & Schrier, S. L. (2013) · American Journal of Hematology · doi:10.1002/ajh.23598 · Cited by 281 · see citing works
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Tsubakihara, Y., Nishi, S., Akiba, T., Hirakata, H., Iseki, K., Kubota, M., Kuriyama, S., Komatsu, Y., Suzuki, M., Nakai, S., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00836.x · Cited by 278 · see citing works
Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial
Nichol, A., French, C., Little, L., Haddad, S. H., Presneill, J., Arabi, Y. M., Bailey, M., Cooper, D. J., Duranteau, J., Huet, O., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00386-4 · Cited by 275 · see citing works
Lipid management in patients with chronic kidney disease
Ferro, C. J., Mark, P. B., Kanbay, M., Sarafidis, P. A., Heine, G. H., Rossignol, P., Massy, Z. A., Mallamaci, F., Valdivielso, J. M., Małyszko, J., et al. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0072-9 · Cited by 275 · see citing works
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD
Kliger, A. S., Foley, R. N., Goldfarb, D. S., Goldstein, S. L., Johansen, K. L., Singh, A. K., & Szczech, L. A. M. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.06.008 · Cited by 270 · see citing works
Ghali, J. K., Anand, I. S., Abraham, W. T., Fonarow, G. C., Greenberg, B., Krum, H., Massie, B. M., Wasserman, S. M., Trotman, M., Sun, Y. P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.698514 · Cited by 268 · see citing works
Alternatives to blood transfusion
Spahn, D. R., & Goodnough, L. T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60808-9 · Cited by 269 · see citing works
Chronic kidney disease and cardiovascular complications
Lullo, L. D., House, A. A., Gorini, A., Santoboni, A., Russo, D., & Ronco, C. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9460-9 · Cited by 266 · see citing works
Provenzano, R., Besarab, A., Wright, S., Dua, S., Zeig, S., Nguyen, P., Poole, L., Saikali, K. G., Saha, G. C., Hemmerich, S., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.020 · Cited by 265 · see citing works
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Spinowitz, B., Kausz, A. T., Baptista, J., Noble, S., Sothinathan, R., Bernardo, M. V., Brenner, L., & Pereira, B. J. G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101156 · Cited by 261 · see citing works
Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD
Chertow, G. M., Pérgola, P. E., Farag, Y. M. K., Agarwal, R., Arnold, S., Bako, G., Block, G. A., Burke, S. K., Castillo, F. P., Jardine, A. G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035938 · Cited by 261 · see citing works
2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Yamamoto, H., Nishi, S., Tomo, T., Masakane, I., Saito, K., Nangaku, M., Hattori, M., Suzuki, T., Morita, S., Ashida, A., et al. (2017) · Renal Replacement Therapy · doi:10.1186/s41100-017-0114-y · Cited by 254 · see citing works
CKiD (CKD in Children) Prospective Cohort Study: A Review of Current Findings
Wong, C. J., Moxey‐Mims, M., Jerry-Fluker, J., Warady, B. A., & Furth, S. L. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.018 · Cited by 250 · see citing works
Besarab, A., Chernyavskaya, E. A., Motylev, I., Shutov, E. V., Kumbar, L. M., Gurevich, K., Chan, D. T. M., Leong, R., Poole, L., Zhong, M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030241 · Cited by 250 · see citing works
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis
Singh, A. K., Carroll, K., Perkovic, V., Solomon, S. D., Jha, V., Johansen, K. L., Lópes, R. D., Macdougall, I. C., Obrador, G. T., Waikar, S. S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2113379 · Cited by 254 · see citing works
Erythropoiesis-Stimulating Agents — Time for a Reevaluation
Unger, E. F., Thompson, A. M., Blank, M. J., & Temple, R. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0912328 · Cited by 247 · see citing works
Erythropoietins: A common mechanism of action
Elliott, S., Pham, E., & Macdougall, I. C. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.08.003 · Cited by 246 · see citing works
The Scope of Coronary Heart Disease in Patients With Chronic Kidney Disease
Hage, F. G., Venkataraman, R., Zoghbi, G. J., Perry, G. J., DEMATTOS, A. M., & Iskandrian, A. E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.047 · Cited by 246 · see citing works
ErythropoietinPreprint
Bunn, H. F. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011619 · Cited by 247 · see citing works
Anemia, Diabetes, and Chronic Kidney Disease
Mehdi, U. F., & Toto, R. D. (2009) · Diabetes Care · doi:10.2337/dc08-0779 · Cited by 244 · see citing works
Pérgola, P. E., Spinowitz, B., Hartman, C., Maroni, B. J., & Haase, V. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.07.019 · Cited by 239 · see citing works
Cobo, G., Hecking, M., Port, F. K., Exner, I., Lindholm, B., Stenvinkel, P., & Carrero, J. J. (2016) · Clinical Science · doi:10.1042/cs20160047 · Cited by 244 · see citing works
Glaspy, J. A., Crawford, J., Vansteenkiste, J., Henry, D. H., Rao, S. V., Bowers, P., Berlin, J. A., Tomita, D. K., Bridges, K. R., & Ludwig, H. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605498 · Cited by 237 · see citing works
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y.-F. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.030 · Cited by 236 · see citing works
Drawz, P. E., & Rahman, M. U. (2015) · Annals of Internal Medicine · doi:10.7326/aitc201506020 · Cited by 233 · see citing works
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
Hanna, R. M., Streja, E., & Kalantar‐Zadeh, K. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01524-6 · Cited by 235 · see citing works
. Prediction, progression and outcomes of chronic kidney disease in older adults.
Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080860 · Cited by 218 · see citing works
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction
Najjar, S. S. (2011) · JAMA · doi:10.1001/jama.2011.592 · Cited by 219 · see citing works
- Authors
- Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D.
- Affiliations
- Brigham and Women's Hospital (US)
- Duke Medical Center (US)
- Duke University (US)
- Duke Clinical Research Institute (US)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-11-16
- Volume
- 355
- Issue
- 20
- Pages
- 2085-2098
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2040029744
- Cited by
- 2,762
- References
- 32
- Citations by year
- 2026: 57 · 2025: 64 · 2024: 73 · 2023: 95 · 2022: 95 · 2021: 116 · 2020: 121 · 2019: 116 · 2018: 92 · 2017: 101 · 2016: 108 · 2015: 114 · 2014: 155 · 2013: 176 · 2012: 182
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Keywords
- epoetin alfa, chronic kidney disease, anemia of chronic kidney disease, hemoglobin target, erythropoietin deficiency, cardiovascular events, congestive heart failure, myocardial infarction, stroke, mortality, quality of life, adverse events
- MeSH terms
- Epoetin Alfa, Aged, Anemia, Erythropoietin, Female, Glomerular Filtration Rate, Heart Failure, Hematinics, Hemoglobins, Hospitalization, Humans, Male, Middle Aged, Myocardial Infarction, Recombinant Proteins, Survival Analysis, Stroke, Renal Insufficiency, Chronic, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
